Prudential Financial Inc Myriad Genetics Inc Transaction History
Prudential Financial Inc
- $74.4 Billion
- Q2 2025
A detailed history of Prudential Financial Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Prudential Financial Inc holds 342,684 shares of MYGN stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
342,684
Previous 175,661
95.08%
Holding current value
$2.17 Million
Previous $1.56 Million
16.75%
% of portfolio
0.0%
Previous 0.0%
Shares
37 transactions
Others Institutions Holding MYGN
# of Institutions
235Shares Held
95.6MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$95.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$58.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$31.2 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$30.4 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$29 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $510M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...